Organigram Global (OGI) Long-Term Investments (2018 - 2023)
Organigram Global (OGI) posted quarterly Long-Term Investments of $3.9 million for Q3 2023, down 19.28% quarter-over-quarter from $4.9 million in Q3 2022.
Organigram Global (OGI) Long-Term Investments (2018 - 2023) Analysis & Trends
Organigram Global (OGI) has reported Long-Term Investments for 6 consecutive years, with $3.9 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Long-Term Investments changed N/A year-over-year to $3.9 million; the TTM figure through Sep 2023 stood at $3.9 million (changed N/A YoY), while the FY2023 annual figure was $3.9 million, changed N/A from the prior year.
- Long-Term Investments fell to $3.9 million in Q3 2023 per OGI's latest filing, from $4.9 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $12.7 million in Q2 2019 and bottomed at -$12.7 million in Q1 2019.
- Historically, Long-Term Investments has averaged $5.6 million across 5 years, with a median of $5.2 million in 2020.
- On a YoY basis, Long-Term Investments climbed as much as 169.96% in 2020 and fell as far as 59.09% in 2020.
- Organigram Global's Long-Term Investments stood at $8.4 million in 2019, then gained by 11.48% to $9.4 million in 2020, then tumbled by 47.86% to $4.9 million in 2021, then dropped by 0.03% to $4.9 million in 2022, then decreased by 19.28% to $3.9 million in 2023.
- Business Quant data shows OGI's Long-Term Investments at $3.9 million in Q3 2023, $4.9 million in Q3 2022, and $4.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 60.00 Mn |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 3.94 Mn |
| Aug 31, 2022 | 4.88 Mn |
| Nov 30, 2021 | 4.88 Mn |
| Aug 31, 2021 | 4.04 Mn |
| May 31, 2021 | 8.52 Mn |
| Feb 28, 2021 | 9.02 Mn |
| Nov 30, 2020 | 9.37 Mn |
| Aug 31, 2020 | 5.21 Mn |
| May 31, 2020 | 5.20 Mn |
| Feb 29, 2020 | 8.89 Mn |
| Aug 31, 2019 | 8.40 Mn |
| May 31, 2019 | 12.72 Mn |
| Feb 28, 2019 | -12.71 Mn |
| Nov 30, 2018 | -12.71 Mn |